Shop now at www.atopis.com Atopis has been successfully launched online and is open for business. A soft launch commencing in January 2017 has already shown a rapid uptake of product generating sales from across New Zealand. Marketing initiatives targeting the USA and other countries are being implemented and will continue across the year.
Callaghan Innovation give recognition to the science and achievements made by Dr. Iona Weir and Atopis™ to date. It is through the generous support of Callaghan Innovation, coupled with the ongoing assistance of NZTE, that the science and business opportunities behind Atopis™ have been able to take such a rapid leap towards reaching global interest. For the full Callaghan Innovation press release click here The Callaghan press release has also been presented to Businessdesk and released on Scoop NZ and the National Business Review. Please click the links to view.
We proudly announce that The International Journal of Phytocosmetics and Natural Ingredients released their publication on Atopis™ 22 March 2016. For full details of the publication please click the link below. PDF: Click here for the PDF Abstract: Click here to link to the abstract
A second successful clinical trial carried out in New Zealand by Southern Clinical Trials Group Ltd, has been completed as scheduled at the end of 2015. The double blinded, placebo (emollient) controlled clinical trial with 62 eczema subjects has demonstrated that Atopis significantly reduces the symptoms of eczema including intensity, severity, itching and scaling.
Decima Health Ltd now has two patents that cover both Atopis and the Development Platform successfully passed examination by the New Zealand Patent Office. The NZ patents are now in the process of being granted. This has exciting implications for Bionona's global business development. The World patent is still pending and is proceeding through the examination process in various jurisdictions.